Piperazine derivatives useful as CCR5 antagonists

Details for Australian Patent Application No. 2006306491 (hide)

Owner Schering Corporation

Inventors Ramanthan, Ragulan; Alton, Kevin B.; Chowdhury, Swapan K.; Ghosal, Anima; Miller, Michael W.

Agent Griffith Hack

Pub. Number AU-A-2006306491

PCT Pub. Number WO2007/050375

Priority 11/255,643 21.10.05 US

Filing date 18 October 2006

Wipo publication date 3 May 2007

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07H 17/02 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050375 Priority application(s): WO2007/050375

17 July 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read: Ramanathan, Ragulan

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306496-Tyrosine kinase inhibitors

2006306487-Heat exchanger assembly for a charge air cooler